AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca global Restricted Stock Plan (GRSP) — Awards outstanding over Ordinary Shares (shares)
Form 20-F Note 29 — Share-Based Payments
Latest, FY2025
2,934
Period ended Dec 31, 2025
Change on a year earlier
-7.4%
3,169 in FY2024
History
8 years
Since FY2018
Sources
4
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Global Restricted Stock Plan (GRSP) — Awards outstanding over Ordinary Shares (shares) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,934 | -7.4% | Form 20-F FY2025 Annual Report ↗ |
| FY2024 | Dec 31, 2024 | 3,169 | +9.4% | Form 20-F FY2025 Annual Report ↗ |
| FY2023 | Dec 31, 2023 | 2,897 | +17.3% | Form 20-F FY2025 Annual Report ↗ |
| FY2022 | Dec 31, 2022 | 2,469 | +21.7% | Form 20-F FY2025 Annual Report ↗ |
| FY2021 | Dec 31, 2021 | 2,028 | +24.7% | Form 20-F FY2024 Annual Report ↗ |
| FY2020 | Dec 31, 2020 | 1,626 | +22.4% | Form 20-F FY2023 Annual Report ↗ |
| FY2019 | Dec 31, 2019 | 1,328 | +32.7% | Form 20-F FY2023 Annual Report ↗ |
| FY2018 | Dec 31, 2018 | 1,001 | – | Form 20-F FY2022 Annual Report ↗ |
Cite this data
StockData. (2026). AstraZeneca Global Restricted Stock Plan (GRSP) — Awards outstanding over Ordinary Shares (shares), annual FY2018–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/sbc_out_grsp_ord
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.